Stock Chart Icon Stock chart icon Cassava Sciences' year-to-date stock performance.
Cassava Sciences : "They do have an Alzheimer's trial, but Lilly has an Alzheimer's formulation that is very good.
And Lilly does have the edge on everybody else."
Stock Chart Icon Stock chart icon Mobileye Global's year-to-date stock performance.
Mobileye Global : "...I think it's just too hard to tell, I'm going to stay away from it."
Persons:
Lilly, Mobileye
Organizations:
Mobileye